# Glycemic Control

---


<img width="874" alt="image" src="https://github.com/user-attachments/assets/9d1f0da0-d2c4-477e-b757-467c7d4bbf11" />



## I. Considerations

- For insulin-naive patients, basal insulin (glargine) should be ordered to begin on **hospital day 2** after glucose checks  
  * If BG remains <180, consider continuing only **sliding scale insulin (SSI)**  
- Basal insulin should **not** be held if the patient is NPO  
- All patients with insulin orders should also have the **Adult Hypoglycemia Management** order set  
- Use caution in:
  * Renal dysfunction  
  * Elderly patients  
  * Patients on glucocorticoids  
  * Large volume fluid shifts  
- Discontinue sliding scale and glucose monitoring if:
  * Glucose remains **<150 mg/dL for 24 hours**
  * Patient is on goal diet

---

## II. Choice of Sliding Scale

- **Patients without DM**: `(BG - 100) / 50`
- **DM on 1–2 oral meds or GLP-1 agonists**: `(BG - 100) / 30`
- **DM on >2 oral meds or insulin at home**: `(BG - 100) / 20`
- **DM on insulin and A1c >9%**: `(BG - 100) / 15`

---

## III. Insulin Infusion

- If glucose **>250 mg/dL** despite maximal sliding scale administration:
  * Consider transfer to **SICU** for intensive glucose management
- Refer to **SICU Glycemic Control Guideline**

---

## IV. Indications for Endocrinology Consultation

- Type I Diabetes Mellitus  
- Use of concentrated insulin **U-500** at home  
- Use of **insulin pump** at home  
- Discharge recommendations/follow-up in patients with:
  * New DM diagnosis and A1c > 6.5%  
  * Known DM with A1c > 9%

---

## V. References

1. Yendamuri S, et al. *J Trauma*. 2003;55:33–38  
2. Laird A, et al. *J Trauma*. 2004;56:1058–1062  
3. Sung J, et al. *J Trauma*. 2005;59:80–83  
4. Van den Berghe G, et al. *N Engl J Med*. 2001;345:1359–1367  
5. NICE-SUGAR Investigators. *N Engl J Med*. 2009;360:1283–1297  
6. Jacobi J, et al. *Crit Care Med*. 2012;40:3251–3276  
7. Mowery NT, et al. *J Trauma*. 2010;68:342–347  
8. Mowery NT, et al. *World J Surg*. 2011;36:270–277  
9. Krinsley J, et al. *Crit Care Med*. 2008;36:3008–3013  
10. Kauffmann RM, et al. *JPEN*. 2011;35:686–694  
11. Bode BW, et al. *Endocr Pract*. 2004;10(2):71–80

---

## VI. Authors

- Michael J. Derickson, MD  
- Kelli Rumbaugh, PharmD, BCPS, BCCCP  
- Jade Flynn, PharmD, BCPS
